A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. [electronic resource]
Producer: 20050124Description: 393-7 p. digitalISSN:- 1078-1439
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Deoxycytidine -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Kidney -- physiology
- Male
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
- Survival Analysis
- Treatment Outcome
- Ureteral Neoplasms -- drug therapy
- Urinary Bladder Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.